Technical Analysis for ANTX - AN2 Therapeutics, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| A | 18.43 | 3.37% | 0.60 |
ANTX closed up 3.37 percent on Monday, May 16, 2022, on 1.57 times normal volume. The bulls were able to push the stock to a new 52-week high. The price action carved out a bearish shooting star candlestick pattern. That may indicate a downside reversal. Look for price to trade beneath the low of the shooting star for confirmation.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | N/A | N/A | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Shooting Star Candlestick | Bearish | 0.00% | |
| Lizard Bearish | Bearish Day Trade Setup | 0.00% | |
| New 52 Week Closing High | Bullish | 0.00% | |
| Wide Range Bar | Range Expansion | 0.00% | |
| Doji - Bearish? | Reversal | 0.00% | |
| New 52 Week High | Strength | 0.00% | |
| Multiple of Ten Bearish | Other | 0.00% | |
| Outside Day | Range Expansion | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Up 3 Days in a Row | Strength | 0.00% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
| Alert | Time |
|---|---|
| No Alerts Yet. Alerts will only show here if at least one person is tracking alerts on this stock. | |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: ???
AN2 Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for rare, chronic, and serious infectious diseases. It is developing epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial lung disease. The company was incorporated in 2017 and is headquartered in Menlo Park, California.
Sector: Other
Industry: Other
Keywords: Biopharmaceutical Infectious Diseases Microbiology Bacteriology Tuberculosis Nontuberculous Mycobacteria Serious Infectious Diseases
Classification
Sector: Other
Industry: Other
Keywords: Biopharmaceutical Infectious Diseases Microbiology Bacteriology Tuberculosis Nontuberculous Mycobacteria Serious Infectious Diseases
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 23.58 |
| 52 Week Low | 12.46 |
| Average Volume | 60,982 |
| 200-Day Moving Average | 0.00 |
| 50-Day Moving Average | 0.00 |
| 20-Day Moving Average | 16.27 |
| 10-Day Moving Average | 17.51 |
| Average True Range | 1.94 |
| RSI | 64.41 |
| ADX | 22.23 |
| +DI | 37.97 |
| -DI | 17.87 |
| Chandelier Exit (Long, 3 ATRs) | 17.75 |
| Chandelier Exit (Short, 3 ATRs) | 18.29 |
| Upper Bollinger Bands | 19.13 |
| Lower Bollinger Band | 13.41 |
| Percent B (%b) | 0.88 |
| BandWidth | 35.14 |
| MACD Line | 0.81 |
| MACD Signal Line | 0.65 |
| MACD Histogram | 0.156 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 28.09 | ||||
| Resistance 3 (R3) | 28.73 | 26.16 | 26.48 | ||
| Resistance 2 (R2) | 26.16 | 23.70 | 25.84 | 25.94 | |
| Resistance 1 (R1) | 22.29 | 22.18 | 24.23 | 21.65 | 25.41 |
| Pivot Point | 19.72 | 19.72 | 20.68 | 19.40 | 19.72 |
| Support 1 (S1) | 15.85 | 17.26 | 17.79 | 15.21 | 11.45 |
| Support 2 (S2) | 13.28 | 15.74 | 12.96 | 10.92 | |
| Support 3 (S3) | 9.41 | 13.28 | 10.38 | ||
| Support 4 (S4) | 8.77 |
